Results of Phase III POLLUX trial on daratumumab in multiple myeloma
MRD: an important topic in myeloma therapy
Myeloma 2016: Panel discussion on the environment biology of myeloma
Dirk Hose et al.
Do immunoglobulin receptor interactions play a role in CLL?
Venetoclax for multiple myeloma - mechanism of action and next steps